The Integrative Treatment of Lyme Disease

Home (Main Menu)

by Steven J. Bock, MD

The International Journal of Integrative Medicine, May/June 1999

See the full article with tables at http://www.patientsamerica.com/cond_xment/lyme.htm

CONFUSING CONDITION
DIAGNOSIS
TREATMENT
NATURAL MEDICINE
COGNITIVE ENHANCEMENT
ACUPUNCTURE
References

Picture this scenario: You have a patient who started feeling fatigued, a kind of fatigue she had never felt before. Various joint started aching in different places, starting with the big joints (hips, knees), elbows, ankles, fingers and toes.

She complains of headaches and pain in the back of the neck. She has problems remembering names or retrieving thoughts. She has no history of arthritis, and no personal or family history of depression.

You elicited a history of flu symptoms a few months ago, but there's no evidence of a tick bite or bull's eye rash, i.e., erythema chronicum migrans (ECM). On the other hand, your patient lives in - or recently traveled to - an endemic area for Lyme disease.

She gives you the history she gave to her general practitioner. Physical examination and initial Lyme test were negative, she was given symptomatic treatment for her symptoms.

Unfortunately, this scenario can happen to all-too-many physicians. Lyme disease starts as a centralized process in the area around the bite, then progresses to an early, then late disseminated state. Approximately 40% to 50% of patients never find a tick bite or ECM rash. Lyme disease can easily be dismissed in it's early stages. Infection can lead to chronic Lyme disease.

Top -- Home

CONFUSING CONDITION

Why is it so difficult to diagnose Lyme disease? Borrelia burgdorferi, a bacterial spirochete, causes the condition. This type of bacteria can invade all parts of the body, including skin, muscles, joints, nervous system, the cardiovascular system, ocular tissue, sinus tissue, gastrointestinal tract, and lungs.

Lyme disease can also mimic different illnesses and syndromes. It is an infection that triggers a variety of host responses, depending on the individual. The spirochete actually burrows into lymphocyte cells, and exits with the cellular membrane surrounding itself.(1) Thus, it can stimulate an immunological response, including autoimmune mechanisms.

Patients with HLA-DR4 and HLA-DR2 genotypes may have genetic predisposition's to chronic Lyme disease.(2) At least one laboratory study reports the IL6-deficient mice have decreased TH2 responses and increased Lyme arthritis.(3)

The complex interaction of the Borrelia spirochete, the host, and the immune response that the bacterium elicited, can explain the varied and often confusing persistence of fatigue and other symptoms of the chronic Lyme patient, even after antibiotic treatment.(4.5.6)

It is possible that dead spirochetes, fragments of spirochetes -- with or without the persistence of live spirochetes -- cause inflammation, cytokine and immune dysregulation, and autoimmunity by molecular mimicry. Autoimmune reactions include positive anticardiolipin antibodies, positive antinuclear antibody (ANA), and positive anti-thyroid antibodies.

Chronic Lyme disease most often produces persistent arthritis, nervous system problems, and cardiac symptoms. It can have many different presentations, depending on

1) which body system is affected,

2) the individual's response to the infection, and

3) the time between initial onset and diagnosis.

Patients can go from physician to physician and get multiple diagnoses, including arthritis, anxiety, depression, and neurological problems such as memory deficits and cognitive dysfunction. (7)

Cognitive dysfunction involves brain processing and word retrieval, and can present as a brain disorder. Borreliosis causes a chronic infection of the nervous system and may produce a syndrome indistinguishable from multiple sclerosis. Fatigue presents as a spectrum that includes fibromyalgia symptoms, all the way to chronic fatigue immune dysfunction syndrome.

Top -- Home

DIAGNOSIS

Antibody assays of Borrelia burgdorferi (BB) can provide evidence of current or previous infection. However, positive tests of BB antibodies do not always indicate current infection, and patients with active Lyme disease can test negative on antibody testing.

Lyme disease is a clinical diagnosis. Testing confirms the diagnosis. First-stage testing is the Enzyme Link Immunoabsorbent Test (ELISA), and Indirect Immunofluoresence Microscopy.

Western Blot (immunoblot) assays are used for secondary-level testing. The Western Blot tests the serum for the presence of numerous KDA antibodies ...

[KDA is kDa -- kiloDaltons, where a Dalton is one atomic mass unit (1/12 the mass of a Carbon-12 atom) -- it is perhaps more meaningful to use the "molar mass" with units of grams/mole]

... KDA antibodies (both IgM and IgG), such as the 18 [molecular "weight"(mass) of 18,000 grams per mole], 21-25, 28, 30, 31, 34, 39, 41, 45, 58, 66, 83, and 93. A Western Blot IgM test of two bands (e.g., 23, 42, or 39, 41) is a positive IgM test.

Five bands on IgG testing constitutes a positive Western Blot analysis by Center for Disease Control (CDC) standards. This is set up on a research basis to make sure no false positives are included in Lyme studies. Many Lyme-positive patients have evidence of three or four bands on testing.

Sero negativity shows about 15% of the time. Sero negativity refers to a negative antibody result, even though the patient has the disease.

Patients may be susceptible to more serious disease when delaying treatment secondary to unrecognized sero negative testing. Patients have had negative testing for up to five years after the onset of symptoms.

Patients diagnosed with multiple sclerosis (MS), living in an epidemic Lyme area, with atypical signs for MS, deserve to be studied fully with Lyme and cerebrospinal fluid (CSF) testing to determine if Lyme disease is an etiology.

Other tests that can be used to support a diagnosis of Lyme disease are polymerase chain reaction (PCR) testing (DNA amplification testing), and the LUAT (Lyme Urinary Antigen Capture Test).(12)

A study by Bayer in 1996 showed that a sizable group of patients diagnosed on clinical grounds as having Lyme disease, may still excrete Borrelia DNA in the urine, despite antibiotic therapy. This is done using a five-day course of antibiotics such as cefuroxine axetil. One takes a urine test on the third, fourth, and fifth day of antibiotic therapy, checking for Lyme antigen. Many a case has been diagnosed while waiting for the results to come back.

An exaggeration of symptoms, a Jarisch Herxheimer reaction (which is due to the spirochete's reaction to being destroyed, similar to what occurs in case of syphilis), or an improvement in symptoms may indicate that the problem is related to Lyme disease.

When encountering resistance to therapy, consider tick-born co-infection with babesiosis or ehrlichiosis. Babesiosis can present wit flu-like symptoms, fever, chills, and low blood count. Ehrlichiosis presents with fatigue, severe headaches, muscle pain, leukopenia, thrombocytopenia, and elevated liver enzymes, Current testing includes serology peripheral blood smears for babesiosis and PCR studies.

Top -- Home

TREATMENT

An integrative medical treatment of Lyme disease starts by considering the whole picture. Look at the patient's recent disease history and symptomatology, genetic tendencies, metabolism, past immune function problems or infection, history of antibiotic treatment and duration of treatment co-infection, nutritional and micronutritional status, and psychospiritual factors.

Treatment depends on the clinical course. an early diagnosis of Lyme disease - by ECM rash, flu symptoms, arthralgia, and other Lyme symptoms-necessitates a six-week course of antibiotics. Supplement this treatment with probiotics to protect the intestinal flora.

The majority of patients seen at Rhinebeck Health Center in New York have chronic symptoms, suggesting possible chronic Lyme disease.

The conventional medical community views Lyme disease as readily treatable with four weeks of antibiotics.(13) Despite the general avoidance of antibiotics in this integrative practice, this author finds that many Lyme patients need prolonged courses of antibiotic therapy.

Patients presenting within Lyme symptomatology are often erroneously labeled as "hypochondriacs." If a patient with chronic Lyme disease has not had an adequate course of antibiotics, but has continuing symptoms with chronic infection, antibiotics are recommended.

Choices include cefuroxine axetil (2,000 mg a day), doxycycline (300 mg a day), clarithromycin (2,000 mg a day), or azithromycin (500 mg a day). Some patients respond will to penicillin G benzathine and penicillin G procaine suspension long-acting penicillin LA, 2.4 million units IM per week (always test for PEN-G allergy by RAST testing).

If intravenous therapy is needed, one can use sterile ceftriaxone sodium, starting at two grams per day; azithromycin at 500 mg per day; or doxycycline at 200 to 400 mg per day.

Top -- Home

NATURAL MEDICINE AND LYME DISEASE

Patients with Lyme disease are placed on a nutritional regimen that includes anti-inflammatory eicosanoids, such as fish oil and borage seed oil. A high potency multivitamin/mineral formula is also used.

Since muscle pain and spasm are present in many cases, a calcium/magnesium supplement is usually prescribed. Extra magnesium is recommended if symptoms are predominantly of a fibromyalgia symptoms are secondary to the underlying disease.

CoQ10 and other mitochondrial nutrients (e.g., carnitine and lipoic acid) promote energy production. Intravenous nutrients, such as vitamin C and B vitamins, are often utilized for immune function enhancement.

The use of electroacupuncture (EAV) is recommended for therapy-resistant problems. This technique picks up underlying deficiencies or excesses of certain acupuncture readings, e.g., liver, large intestine or spleen. It also reportedly detects toxicities that interfere with the body's healing (e.g., mercury toxicity, elimination problems or pesticide toxicity).

When a patient is placed on antibiotic therapy, it is imperative to give him or her probiotics (e.g., Lactobacillus, acidophilus or bifidum) and Saccharomyces boulardii. this prevents imbalance in the intestinal flora, which could lead to intestinal dysbiosis and/or C.dificile infection.

Chronic candidiasis and intestinal dysbiosis are frequently encountered in the treatment of Lyme patients. In some cases, natural anti-fungal therapy is utilized. Nystatin or fluconazole can also be used. Occasionally, intestinal cleansing is necessary. milk thistle extract can help prevent potential dysfunction of liver enzymes from antibiotic therapy.

Top -- Home

COGNITIVE ENHANCEMENT IN Lyme DISEASE

Cognitive difficulties are part of the neurologic syndrome of chronic Lyme disease. The severity of cognitive dysfunction in Lyme disease can fluctuate from day to day and from week to week.

Cognitive difficulties can manifest as an inability to start projects, difficulty in doing multiple tasks, getting lost going places, memory loss, concentration problems, personality changes and irritability.(14)

Psychiatric problems include panic disorder, bipolar disorder, paranoia, schizophrenia, obsessive-compulsive disorder, and in children, attention deficit disorder. (15)

These findings are often documented on neuropsychological testing and SPECT scan. Findings on scans show decreased blood flow to parts of the brain.

Supplements that help with cognitive enhancement include L-Acetyl-Carnitine and antioxidant compounds. Herbal extracts such as Gingko Biloba can also help. For others, cognitive enhancement medications, such as pregnenolone, may be more effective.

In some cases, cognitive abilities improve when sub-clinical hypothyroid problems are treated. Again, one must treat the associated anxiety, depression and sleep disorders. Neurobiofeedback can also help treat the cognitive dysfunction associated with Lyme disease.

Top -- Home

ACUPUNCTURE AND OTHER ALTERNATIVE MODALITIES

One of the postulates of Chinese medicine is that an imbalance of chi (energy flow of the body) causes illness, and that applying acupuncture to certain "meridian" points on the body can correct this imbalance.

The World Health Organization now recognizes Acupuncture as an appropriate treatment for chronic muscular pain, fibromyalgia syndrome, radicular pain, neck pain, muscle tension, headache, low back pain, arthritis and substance abuse.

Acupuncture is also used for problems related to autonomic dysfunction, fatigue, and insomnia. Studies have shown a decreased electrical resistance at acupuncture points, and also that 50% to 70% of acupuncture points correspond to Dr. Travell's trigger points.(16)

A treatment regimen of acupuncture in Lyme disease, combined with physical therapy, can reduce pain, increase mobility, and improve fatigue states.(17) However, one often finds acupuncture treatment can aggravate the symptoms of a herxheimer reaction.

In chronic Lyme disease patients, depending on the clinical situation, various other modalities can be instituted. This involves the use of natural immune-modulating peptides to boost the immune system by supporting the suppressor T-cell function.

With proper complementary or progressive medical approach, and by combining conventional and alternative therapies, we can hopefully lead patients with Lyme disease toward better health.

Steven J. Bock has been practicing alternative and integrative medicine for over 20 years. He has extensive experience in the integrative treatment of Lyme disease.

Dr. Bock is a certified acupuncturist. He is medical director of The Rhinebeck Health Center, The Center for Progressive Medicine and PatientsAmerica.com. He is the author of "Natural Relief for Your Child's Asthma" and "Staying Young the Melatonin Way" (New York: Plume Books, 1996).

International Journal of Integrative Medicine 1(3):19-23, May/June 1999. For information on subscribing to this professional journal, call IMPAKT communications, Inc. at 1-800-477-2995 today.

Top -- Home

References

1. Dorwood D, Fischer: In vitro evidence for lymphocytic membrane cloaking by Borrelia burgdorferi. Lyme Disease Foundation, Scientific Conference, April, 1998.

2. Steere AC, Dwyer E, Winchester R: Arthritis with HLA-DR4 and HLA-DR2 alleses. New England Journal of Medicine 323:219-223, 1990.

3. Anquita J, Timcon M, Samanta S, Barthols SW, flavell RA, Fikrig E: Borrelia burgdorferi infection: interleukin-6 deficient mice have decreased TH-2 responses and increased Lyme arthritis. Journal of Infectious Diseases 178(5):1516-1525, November 1998.

4. Luft BJ, Steinman CR, Dattwyler R: Invasion of the Central Nervous System by Borrelia burgdorferi in Acute Disseminated Infection. JAMA 267(10), march 1992.

5. Georgeilis K, Peacoche M, Klempner MS: Fibroblasts Protect the Lyme Disease Spirochete, Borrelia burgdorferi, From Cefriaxone in Vitro. Journal of Infectious Diseases 166:440-4444, 1992.

6. Preac-Mursic V, Weber K, Pfister, et al: Survival of Borrelia burgdorferi in Antibiotically Treated Patients With Lyme Borreliosis. Infection 17:355-359, 1989.

7. Papavone: Neuropsychiatric Manifestations of Lyme Disease. Journal of American Osteopathic Association 98(7):373-378, July 1998.

8. National Institute of Allergic and Infectious Disease, NIH fact Sheet, May 1997.

9. Ibid.

10. Communication: Institute of Ecosystem Studies, Millbrook, NY.

11. Fein L: Multivariable analysis of 160 patients with Lyme disease. Lyme disease conference, April 19, 1996.

12. Harris N: Antigen detection of Borrelia burgdorferi in urine. Lyme Disease Scientific Conference, April 1998.

13. Nadelman RB, Wormser GP: Lyme Borreliosis. The Lancet 15(352):557-565, August 1998.

14. Communication: Dr. Marian Rissenberg, Neuropsychology. Cognitive Characteristics of Lyme Disease, 10th Annual International Conference, NIH, April 28-30, 1997.

15. Fallon N, et al: Psychiatric manifestations of Lyme Borrelia: Journal of Neuropsychology 54:263-268, 1997.

16. Travell J, et al: Myofascial Pain and Dysfunction. Baltimore: Williams & Wilkins, 1993.

17. Riederer P, Tenk H, Werner H, Bischko J, Rett A, Krisper H: Manipulation of neurotransmitters by acupuncture: a preliminary communication. J Neural Transm 37(1):81-94, 1975.

NINE REASONS FOR FALSE NEGATIVE LYME DISEASE BLOOD TESTS

The Lyme Disease Foundation (LDF), in their brochure entitled "LDF Frequently Asked Questions About Lyme Disease" lists the following nine reasons for false negative Lyme disease test results.

1. Antibodies against Bb are present, but the laboratory is unable to detect them. [Borrelia burgdorferi (Bb) is the Lyme disease bacteria.]

2. Antibodies against Bb may NOT be present in detectable levels in a patient with Lyme disease because the patient is currently on, or has recently taken, antibiotics. The antibacterial effect of antibiotics can reduce the body's production of antibodies.

3. Antibodies against Bb may NOT be present in detectable levels in a patient with Lyme disease because the patient is currently on or has previously taken anti-inflammatory steroidal drugs These can suppress a person's immune system, thus reducing or preventing an antibody response.

4. Antibodies against Bb may NOT be present in detectable levels in a patient with Lyme disease because the patient's antibodies may be bound with the bacteria with not enough free antibodies available for testing.

[For this reason, some of the worst cases of Lyme disease test negative -- too much bacteria for the immune system to handle.]

5. Antibodies against Bb may NOT be present in detectable levels in a patient with Lyme disease because the patient could be immunosuppressed for a number of other reasons, and the immune system is not reacting to the bacteria.

6. Antibodies against Bb may NOT be present in detectable levels in a patient with Lyme disease because the bacteria has changed its makeup (antigenic shift) limiting recognition by the patient's immune system.

7. Antibodies against Bb may NOT be present in detectable levels in a patient with Lyme disease because the patient's immune response has not been stimulated to produce antibodies, i.e., the blood test is taken too soon after the tick-bite (8-6 weeks).

Please do not interpret this statement as implying that you should wait for a positive test to begin treatment.

8. Antibodies against Bb may NOT be present in detectable levels in a patient with Lyme disease because the laboratory has raised its cutoff too high.

9. Antibodies against Bb may NOT be present in detectable levels in a patient with Lyme disease because the patient is reacting to the Lyme bacteria, but is not producing the "right" bands to be considered positive.

Lyme Disease Foundation
1 Financial Plaza
Hartford, CT 06103
(860)525-2000
fax (860)525-TICK
Lyme Disease National Hotline (800)886-LYME
mailto:lymefnd@aol.com

Bug War -- Top -- Home -- What's New